heart failure - Nursing Case Study

Pathophysiology

• Primary mechanism: Heart failure occurs when the heart is unable to pump blood effectively, often due to weakened heart muscle from conditions like coronary artery disease or hypertension. This leads to decreased cardiac output and insufficient blood supply to meet the body's needs.

• Secondary mechanism: The body compensates by activating the renin-angiotensin-aldosterone system (RAAS), which increases blood volume and pressure. However, this compensatory mechanism can overwork the heart and worsen heart failure over time.

• Key complication: Fluid accumulation in lungs and extremities, known as congestion, results from the heart's reduced ability to manage blood volume, leading to symptoms like shortness of breath and swelling in legs and ankles.

Patient Profile

Demographics:

65-year-old male, retired school teacher

History:

• Key past medical history: Hypertension, hyperlipidemia

• Current medications: Lisinopril 10 mg daily, Atorvastatin 20 mg daily

• Allergies: None

Current Presentation:

• Chief complaint: Mild shortness of breath on exertion

• Key symptoms: Occasional fatigue, mild ankle swelling

• Vital signs: Blood pressure 130/80 mmHg, heart rate 78 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, oxygen saturation 96% on room air

Section 1

Initial Assessment Findings:

Upon further assessment, the nurse notes that the patient has mild jugular venous distention (JVD), which is a common sign of fluid overload in heart failure. The patient's lung sounds are clear with no crackles or wheezes, suggesting that pulmonary congestion is minimal at this stage. The patient's skin is warm and dry, indicating that perfusion is presently adequate, and capillary refill time is less than 2 seconds. Peripheral pulses are palpable and strong, but the mild pitting edema observed on the ankles confirms fluid retention, consistent with his complaint of lower extremity swelling.

The patient's electrocardiogram (ECG) shows normal sinus rhythm with no acute ischemic changes, indicating stable cardiac electrical activity. A recent echocardiogram reveals a left ventricular ejection fraction of 45%, which is slightly reduced, confirming early-stage heart failure but without severe impairment. Blood tests show a slightly elevated B-type natriuretic peptide (BNP) level of 150 pg/mL, which supports the diagnosis of heart failure, as BNP levels tend to rise when the heart is under stress from fluid overload.

These assessment findings suggest that the patient is in a compensated state of heart failure, where symptoms are mild and manageable. The care plan will focus on optimizing medication therapy, such as potentially titrating the dosage of Lisinopril and considering the addition of a diuretic to manage fluid retention. Patient education will also be vital, emphasizing lifestyle modifications like dietary sodium restriction and regular physical activity to prevent progression of the disease. This stage of management provides a strong foundation to monitor for any changes in the patient's condition that may necessitate adjustments to the treatment plan.

Section 2

Response to Interventions

Following the initial assessment and implementation of the care plan, the patient begins treatment with a low-dose diuretic, Furosemide, alongside continued Lisinopril therapy. After one week of treatment, the patient returns for a follow-up visit. During this visit, the nurse conducts a reassessment to evaluate the effectiveness of the interventions. The patient's vital signs are stable with a blood pressure of 128/76 mmHg and a heart rate of 78 beats per minute. The patient reports feeling less fatigued and notes a noticeable reduction in swelling of the lower extremities.

On physical examination, the nurse observes that the jugular venous distention (JVD) has decreased, and the pitting edema around the ankles has improved, now barely perceptible. Lung sounds remain clear, and the patient's skin continues to be warm and dry, with a capillary refill time of less than 2 seconds. The peripheral pulses are still strong and palpable. The patient's weight has decreased by 2 pounds since the previous visit, indicating effective fluid management.

Laboratory results show a slight decrease in B-type natriuretic peptide (BNP) levels, now at 120 pg/mL, suggesting a reduction in cardiac stress and fluid overload. The patient's serum electrolytes, including potassium, are within normal range, indicating that the diuretic therapy is being tolerated well without causing electrolyte imbalances. The positive response to the interventions reinforces the importance of medication adherence, dietary modifications, and regular follow-up visits to monitor and manage the patient's early-stage heart failure effectively. The care team plans to continue the current treatment regimen while closely monitoring for any signs of disease progression or potential complications.

Section 3

During the follow-up visit, the nurse also reviews the patient’s dietary and lifestyle modifications, as these play a crucial role in managing early-stage heart failure. The patient reports adherence to a low-sodium diet and increased physical activity, which have contributed to their overall improvement. However, the nurse notes that the patient occasionally experiences mild dizziness upon standing, which could indicate orthostatic hypotension, a potential side effect of the diuretic therapy. To address this, the nurse emphasizes the importance of rising slowly from sitting or lying positions and staying well-hydrated while maintaining sodium restrictions.

The nurse provides education on recognizing symptoms that may require immediate attention, such as sudden weight gain, increased swelling, or shortness of breath. Additionally, the patient is encouraged to keep a daily log of their weight, blood pressure, and any symptoms to help in early detection of any changes. The nurse reinforces the importance of medication adherence, including taking furosemide in the morning to avoid nocturia and ensuring consistent use of Lisinopril to manage blood pressure and support heart function.

As the patient prepares for the next follow-up appointment in a month, the care team decides to continue monitoring the current regimen’s effectiveness. They schedule routine laboratory tests to check renal function and electrolyte levels, given the ongoing use of diuretics. The patient leaves the clinic with a clear understanding of their self-management plan and a renewed confidence in managing their heart failure, armed with the knowledge and support from their healthcare team. The focus remains on maintaining stability and preventing any new complications, ensuring an improved quality of life for the patient.

Section 4

A month later, the patient returns for their follow-up appointment, and the nurse conducts an initial assessment to evaluate the current status of the patient's heart failure management. The patient reports feeling generally well but mentions experiencing occasional fatigue in the afternoons. The nurse notes that the patient appears well-nourished and hydrated, and their weight has remained stable over the past month, which is a positive indicator. Vital signs are taken, revealing a blood pressure of 118/76 mmHg and a heart rate of 72 beats per minute, both within normal limits. The patient’s recent self-monitoring log shows consistent daily weights without significant fluctuations, and no episodes of nocturia or dizziness have been recorded since the last visit.

In reviewing the results of the routine laboratory tests performed prior to this visit, the nurse finds that the patient's renal function and electrolyte levels remain within normal ranges. Serum creatinine is 1.0 mg/dL, and potassium levels are at 4.2 mEq/L, indicating that the diuretic therapy has not adversely affected kidney function or electrolyte balance. This reassures both the patient and the healthcare team that the current treatment regimen continues to be effective without causing additional complications.

The nurse congratulates the patient on their diligent self-management and adherence to lifestyle modifications, emphasizing the importance of maintaining these habits. The patient is reminded to continue monitoring their weight, blood pressure, and any potential symptoms, as early detection of changes can prevent complications. They are encouraged to remain active while listening to their body’s needs, particularly in managing occasional fatigue by pacing activities throughout the day. The healthcare team decides to maintain the current treatment plan and schedules another follow-up in three months, aiming to sustain stability in the patient's condition and further enhance their quality of life.

Section 5

Three months later, the patient returns for the scheduled follow-up appointment. During the initial assessment, the nurse observes that the patient continues to appear well-nourished and well-hydrated, with no significant changes in weight since the last visit. The patient reports feeling generally well, with occasional mild fatigue, but notes a new symptom of mild swelling in the ankles by the end of the day. Despite this, the patient maintains an active lifestyle and adheres to dietary recommendations.

Vital signs are reassessed, showing a blood pressure of 120/78 mmHg and a heart rate of 70 beats per minute, both of which remain within normal limits. The patient’s self-monitoring log continues to reflect stable daily weights without significant fluctuations. However, the patient has noted a slight increase in ankle circumference in the evenings, which resolves by morning. The nurse performs a physical examination, confirming mild, non-pitting edema in both ankles.

Considering these findings, the healthcare team decides to conduct further diagnostic tests to evaluate the patient's fluid status and cardiac function. A repeat echocardiogram is ordered to assess ejection fraction and overall cardiac performance, while additional blood tests are requested to check for any changes in renal function or electrolyte levels. The team plans to review these results to determine if any adjustments to the diuretic regimen are necessary to address the new symptom of edema, ensuring the patient’s heart failure remains well-managed without compromising renal function. The patient is educated on the importance of continuing self-monitoring and reporting any new or worsening symptoms promptly.